3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NIH
2
NETWORK
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
56
Lung Neoplasms
48
Leukemia, Myeloid, Acute
44
Breast Neoplasms
37
Carcinoma, Non-Small-Cell Lung
36
Myelodysplastic Syndromes
27
Pancreatic Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Multiple Myeloma
23
Colorectal Neoplasms
23
Carcinoma, Renal Cell
22
Neoplasm Metastasis
20
Melanoma
20
Glioblastoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
17
Brain Neoplasms
16
Triple Negative Breast Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
12
Carcinoma, Hepatocellular
12
Lymphoma, Mantle-Cell
11
Lymphoma, B-Cell
11
Leukemia, Myelomonocytic, Chronic
11
Fallopian Tube Neoplasms
11
Rectal Neoplasms
10
Myeloproliferative Disorders
10
Lymphoma, Follicular
10
Colonic Neoplasms
10
Hematopoietic and Lymphatic System Neoplasm
9
Interventions
Cyclophosphamide
16
Temozolomide
13
Vincristine
10
Irinotecan
8
Melphalan
7
Doxorubicin
7
Topotecan
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
fludarabine
5
cabozantinib
5
Etoposide
5
Drug Therapy
5
liposomal doxorubicin
4
Sirolimus
4
Ifosfamide
4
Filgrastim
4
regorafenib
3
pegfilgrastim
3
irinotecan sucrosofate
3
fludarabine phosphate
3
Zoledronic Acid
3
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Gemcitabine
3
Cisplatin
3
Bone Marrow Transplantation
3
Albumin-Bound Paclitaxel
3
pegylated granulocyte colony-stimulating factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Ewing
×
Specimen Handling
×
Clear all
NCT07188532
2026-06-04
BEAR
Mayo Clinic
Phase NA
Recruiting
141 enrolled